Back to Search
Start Over
Patent Issued for Use of sublingual dexmedetomidine for the treatment of agitation (USPTO 11786508)
- Source :
- Mental Health Weekly Digest. November 6, 2023, 1390
- Publication Year :
- 2023
-
Abstract
- 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- BioXcel Therapeutics Inc. (New Haven, Connecticut, United States) has been issued patent number [...]
Details
- Language :
- English
- ISSN :
- 15436616
- Database :
- Gale General OneFile
- Journal :
- Mental Health Weekly Digest
- Publication Type :
- News
- Accession number :
- edsgcl.771581845